Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
About this episode
Heather Brown discusses the implications of Epstein-Barr virus in multiple sclerosis with experts Jan Lünemann and Christian Münz.
In this episode, Heather Brown, Senior Editor at The Lancet Neurology, chats with Jan Lünemann (University of British Columbia, Canada) and Christian Münz (University of Zürich, Switzerland) about their Rapid Review on Epstein-Barr virus (EBV) and multiple sclerosis (MS). EBV, a common herpesvirus, has been strongly implicated in development of MS, and recent mechanistic advances are providing new insights into how EBV might cause MS in some people but not others. We also discuss the potential for prevention of MS with EBV vaccines, whether therapies targeting EBV might eventually be useful for MS treatment, and important unanswered questions and next steps for the field. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00177-8/fulltext
More episodes of The Lancet Neurology in conversation with
- Hal Dietz discusses the role of genetics in spinal CSF leaks
- Tony Schapira on GBA1 Parkinson's disease
- Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s disease
- Cristina Tassorelli on migraine prevention
- Inga Zerr and Simon Mead on advances in prion diseases
- Julia Greenland on azathioprine for early Parkinson’s disease
Explore listener stats, chart rankings, contacts and more on the The Lancet Neurology in conversation with podcast page.